J. Bancroft et A. Cook, THE NEUROENDOCRINE RESPONSE TO D-FENFLURAMINE IN WOMEN WITH PREMENSTRUAL DEPRESSION, Journal of affective disorders, 36(1-2), 1995, pp. 57-64
An oral d-fenfluramine neuroendocrine challenge test was carried out i
n 17 women with premenstrual depression and 14 controls, twice in each
subject, once in the late luteal phase when mood change was likely to
be at its worst (i.e. premenstrual) and once postmenstrually. Women w
eighing < 65 kg received 15 mg, the remainder 30 mg of d-fenfluramine.
Although there was considerable individual variability, a substantial
average prolactin response was observed in both groups but no phase,
group or group X phase interaction effects were found. Oestradiol leve
ls were significantly higher during the postmenstrual test but showed
no relationship to prolactin response. Cortisol showed a more modest r
esponse to the drug and a phase effect was found, with cortisol increa
se being greater during the postmenstrual test in both groups. In cont
rast to earlier findings with i.v. L-tryptophan challenge, the present
study failed to show any difference in neuroendocrine response betwee
n women with premenstrual depression and controls. These results sugge
st that 5-hydroxy-tryptophan, receptor function is unaltered in perime
nstrual mood disorder although other interpretations of the negative f
indings are discussed.